Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
66.0%
% of FTXH's 51 holdings also in IBBQ
15.1%
% of IBBQ's 218 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus IBBQ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in IBBQ |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 3.6% | 8.0% | 3.6% |
|
GILEAD SCIENCES INC | 3.6% | 7.9% | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.5% | 7.1% | 3.5% |
|
BIOGEN IDEC INC | 3.5% | 2.0% | 2.0% |
|
UNITED THERAPEUTICS CORP | 3.7% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to IBBQ
|
ABBVIE INC | 7.6% |
|
JOHNSON & JOHNSON | 7.5% |
|
PFIZER INC | 7.3% |
|
MERCK & CO. INC. | 7.2% |
|
BRISTOL-MYERS SQUIBB CO | 6.8% |
|
ZOETIS INC | 3.7% |
|
ELI LILLY & CO | 3.6% |
|
VIATRIS, INC. | 2.6% |
 |
JAZZ PHARMACEUTICALS PLC | 2.5% |
|
UNITED THERAPEUTICS CORP | 2.2% |
FTXH Underweight Relative to IBBQ
|
VERTEX PHARMACEUTICALS INC | -8.5% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.6% |
|
AMGEN INC | -4.3% |
|
GILEAD SCIENCES INC | -4.3% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
ALNYLAM PHARMACEUTICALS INC | -3.1% |
 |
ARGENX SE ADR | -2.3% |
|
SUMMIT THERAPEUTICS INC | -2.2% |
 |
SANOFI-AVENTIS-ADR | -1.7% |
|
ROYALTY PHARMA PLC CLASS A | -1.6% |